F2R and cancer: Additionally, the plasmin-activated MMP-1 and MMP-13 also cleave the N-terminal exodomain of PAR-1, but at sites alternative to those of thrombin and FXa, to elicit distinct cellular responses thought to be relevant in cancer and rheumatoid arthritis pathology [81].